Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.48M Buy
9,882
+252
+3% +$89.8K 0.39% 60
2025
Q4
$3.15M Buy
9,630
+3,905
+68% +$1.24M 0.35% 61
2025
Q3
$1.62M Sell
5,725
-79
-1% -$22.9K 0.18% 97
2025
Q2
$1.62M Buy
5,804
+44
+0.8% +$12.5K 0.19% 90
2025
Q1
$1.79M Sell
5,760
-1,473
-20% -$435K 0.25% 74
2024
Q4
$1.89M Sell
7,233
-404
-5% -$120K 0.28% 61
2024
Q3
$2.46M Sell
7,637
-17
-0.2% -$5.56K 0.36% 61
2024
Q2
$2.39M Buy
7,654
+2
+0% +$588 0.38% 57
2024
Q1
$2.18M Buy
7,652
+947
+14% +$277K 0.36% 58
2023
Q4
$1.93M Sell
6,705
-13
-0.2% -$3.54K 0.38% 54
2023
Q3
$1.81M Sell
6,718
-39
-0.6% -$9.73K 0.43% 50
2023
Q2
$1.5M Hold
6,757
0.35% 57
2023
Q1
$1.5M Buy
+6,757
New +$1.66M 0.35% 57

Other funds holding AMGN

NWF Advisory Services's AMGN Position: Q1 2026 in Review

NWF Advisory Services increased its Amgen (AMGN) stake by 2.6% in Q1 2026, buying an estimated $89.8K and bringing the position to 9,882 shares worth $3.48M. The position accounts for 0.39% of the portfolio, ranked #60.

NWF Advisory Services first reported a position in AMGN in Q1 2023 and has held it in 13 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • NWF Advisory Services held 9,882 shares of Amgen worth $3.48M as of Q1 2026.
  • NWF Advisory Services bought 252 Amgen shares in Q1 2026, an estimated $89.8K.
  • Amgen made up 0.39% of NWF Advisory Services's portfolio in Q1 2026, its #60 holding.
  • NWF Advisory Services first reported a position in Amgen in Q1 2023 and has held it in 13 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.